ClassID:

21554

A61K51/0468 - CPC Classification

Classification description:

Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Sub-classes:
Recent Application in this class:
#1
20250170124
2025-05-29

METHODS OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASES

#2
20250064991
2025-02-27

COMPOUNDS SPECIFIC TO GRANZYME B AND USES THEREOF

#3
20250034149
2025-01-30

DIHYDROPYRROLO[3,4C]-PYRAZOLE DERIVATIVES AND THEIR USE IN DIAGNOSIS

#4
20250032650
2025-01-30

PRODRUGS FOR COMPOUNDS SPECIFIC TO GRANZYME B AND USES THEREOF

#5
20240390530
2024-11-28

GRANZYME B DIRECTED IMAGING AND THERAPY

#6
20240165278
2024-05-23

GRANZYME B DIRECTED IMAGING AND THERAPY

#7
20230338588
2023-10-26

Granzyme B directed imaging and therapy

#8
20230257388
2023-08-17

GRANZYME B DIRECTED IMAGING AND THERAPY

#9
20230248733
2023-08-10

HIGHLY ACTIVE ANTI-NEOPLASTIC AND ANTI-PROLIFERATIVE AGENTS

#10
20220273803
2022-09-01

CHOLECYSTOKININ B RECEPTOR TARGETING FOR IMAGING AND THERAPY

#11
20220118118
2022-04-21

BENZAZEPIN-L,7-DIOL-DERIVED RADIOLABELED LIGANDS WITH HIGH IN VIVO NMDA SPECIFICITY

#12
20220017433
2022-01-20

PHOTOCHEMICALLY INDUCED CONJUGATION OF RADIOMETALS TO SMALL MOLECULES, PEPTIDES AND NANOPARTICLES IN A SIMULTANEOUS ONE-POT REACTION

#13
20210236663
2021-08-05

Compounds and probes for imaging huntingtin protein

#14
20210094920
2021-04-01

NR2B LIGANDS; METHOD OF MAKING; AND USE THEREOF

#15
20200384114
2020-12-10

Cholecystokinin B receptor targeting for imaging and therapy

#16
20200369673
2020-11-26

Granzyme B directed imaging and therapy

#17
20200345743
2020-11-05

HIGHLY ACTIVE ANTI-NEOPLASTIC AND ANTI-PROLIFERATIVE AGENTS

#18
20200147243
2020-05-14

LIGAND COMPOUND OF ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AND APPLICATION THEREOF

#19
20190224348
2019-07-25

Granzyme B directed imaging and therapy

#20
20190125752
2019-05-02

Highly active anti-neoplastic and anti-proliferative agents

#21
20190076538
2019-03-14

Cholecystokinin B receptor targeting for imaging and therapy

#22
20180326100
2018-11-15

Radiolabeled Tracers for Poly (ADP-RIBOSE) Polymerase-1 (PARP-1), Methods and Uses Therefor

#23
20180015096
2018-01-18

HIGHLY ACTIVE ANTI-NEOPLASTIC AND ANTI-PROLIFERATIVE AGENTS

#24
20170296682
2017-10-19

DERIVATIVES OF DIBENZOTHIOPHENE IMAGING OF alpha-7 NICOTINIC ACETYLCHOLINE RECEPTORS

#25
20170224852
2017-08-10

BENZAZEPIN-1-OL-DERIVED PET LIGANDS WITH HIGH IN VIVO NMDA SPECIFICITY

#26
20160339124
2016-11-24

Radiolabeled tracers for poly (ADP-ribose) polymerase-1 (PARP-1), methods and uses therefor

#27
20160235869
2016-08-18

DERIVATIVES OF DIBENZOTHIOPHENE IMAGING OF alpha-7 NICOTINIC ACETYLCHOLINE RECEPTORS

#28
20150291647
2015-10-15

Compositions and methods for 18F-fluorodeoxyglycosylamines

#29
20150050212
2015-02-19

Cholecystokinin B receptor targeting for imaging and therapy

#30
20140328755
2014-11-06

Highly selective sigma receptor ligands and radioligands as probes in nociceptive processing and the pathphysiological study of memory deficits and cognitive disorders

#31
20140178304
2014-06-26

Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammals

#32
20140030190
2014-01-30

Labelled and un-labelled methyl-pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use

#33
20130287687
2013-10-31

COMPOUNDS, COMPOSITIONS, METHODS OF SYNTHESIS, AND METHODS OF TREATMENT

#34
20130183240
2013-07-18

In vivo imaging method for cancer

#35
20130177501
2013-07-11

In vivo imaging method of mood disorders

#36
20130004428
2013-01-03

Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators

#37
20120288443
2012-11-15

LABELLED PYRROLYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR USE IN DIAGNOSTIC METHODS

#38
20120020884
2012-01-26

Indole derivatives

#39
20120003153
2012-01-05

Indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use

#40
20110305636
2011-12-15

Compounds, compositions, methods of synthesis, and methods of treatment

#41
20110280804
2011-11-17

Highly selective sigma receptor radioligands

#42
20110195955
2011-08-11

Highly selective sigma receptor ligands

#43
20110190492
2011-08-04

DIAGNOSTIC PROBE FOR CONFORMATION DISEASE

#44
20110070161
2011-03-24

Active enantiomer

#45
20100272642
2010-10-28

PET PROBE HAVING AN ALKOXY GROUP SUBSTITUTED BY FLUORINE AND HYDROXY GROUP

#46
20100021385
2010-01-28

Benzoxazole derivatives

#47
20090185975
2009-07-23

DIAGNOSTIC PROBE FOR CONFORMATION DISEASE

#48
20090087378
2009-04-02

Positron Tomography Method and Positron-Emitting Compound to Be Used Therein

#49
20080056991
2008-03-06

PIPERAZINYL AND DIAZAPANYL BENZAMIDES AND BENZTHIOAMIDES

#50
20060051293
2006-03-09

Amyloid plaque aggregation inhibitors and diagnostic imaging agents

#51
20050129612
2005-06-16

Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging